RAGE-Abeta interactions in the pathophysiology of Alzheimer's disease.
Level 5 - mechanism / opinion, no new human data
Bench, cell-culture, and post-mortem tissue study without clinical interventions.
What was done
In vitro binding assays, cell-culture experiments, and post-mortem human brain tissue analyses were conducted to investigate the interaction of amyloid-beta (Abeta 1-40) with the receptor for advanced glycation end-products (RAGE). Methods included immunocytochemistry, chemical cross-linking on endothelial cells, binding affinity measurements using recombinant human RAGE and BV-2 microglial cells, oxidative stress assessments (TBARS and MTT assays in neuronal, endothelial, and RAGE-transfected COS-1 cells), ELISA on Alzheimer's disease versus control brain tissue, and microglial migration assays.
What was found
Abeta bound recombinant human RAGE with a Kd of 57 +/- 14 nM and BV-2 microglial RAGE with a Kd of 25 +/- 9 nM. Cross-linking confirmed a 50 kDa RAGE band on endothelial cells. Abeta-RAGE interaction triggered oxidative stress across tested cell types. Brain tissue ELISA showed a 2.5-fold increase in RAGE expression in Alzheimer's disease compared to control brains. Soluble Abeta promoted concentration-dependent microglial migration, while immobilized Abeta halted it. Abeta-RAGE binding also activated NF-kappaB and upregulated neuronal macrophage-colony stimulating factor (M-CSF).
Why it matters
This study identifies RAGE as a cell-surface target for Abeta, providing a direct biochemical pathway linking amyloid accumulation to oxidative cellular stress and neuroinflammatory microglial recruitment in Alzheimer's disease.
Limits
The findings rely entirely on in vitro cell lines, recombinant proteins, and post-mortem tissue, lacking in vivo animal model verification or clinical trial data. Sample sizes for the human post-mortem brain samples are not reported in the abstract.
Cited by
- supports Beta-amyloid and phosphorylated tau bind to RAGE (receptor for advanced glycation end products) on microglial cell surfaces.